213 related articles for article (PubMed ID: 36752166)
1. In silico analysis of the dynamic regulation of cardiac electrophysiology by K
Meier S; Grundland A; Dobrev D; Volders PGA; Heijman J
J Physiol; 2023 Jul; 601(13):2711-2731. PubMed ID: 36752166
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of pentamidine-affected ion channel trafficking and dofetilide mediated rescue.
Varkevisser R; Houtman MJ; Linder T; de Git KC; Beekman HD; Tidwell RR; Ijzerman AP; Stary-Weinzinger A; Vos MA; van der Heyden MA
Br J Pharmacol; 2013 Jul; 169(6):1322-34. PubMed ID: 23586323
[TBL] [Abstract][Full Text] [Related]
3. Extracellular K+ concentration controls cell surface density of IKr in rabbit hearts and of the HERG channel in human cell lines.
Guo J; Massaeli H; Xu J; Jia Z; Wigle JT; Mesaeli N; Zhang S
J Clin Invest; 2009 Sep; 119(9):2745-57. PubMed ID: 19726881
[TBL] [Abstract][Full Text] [Related]
4. Endocytic control of ion channel density as a target for cardiovascular disease.
Robertson GA
J Clin Invest; 2009 Sep; 119(9):2531-4. PubMed ID: 19726880
[TBL] [Abstract][Full Text] [Related]
5. Interaction between the cardiac rapidly (IKr) and slowly (IKs) activating delayed rectifier potassium channels revealed by low K+-induced hERG endocytic degradation.
Guo J; Wang T; Yang T; Xu J; Li W; Fridman MD; Fisher JT; Zhang S
J Biol Chem; 2011 Oct; 286(40):34664-74. PubMed ID: 21844197
[TBL] [Abstract][Full Text] [Related]
6. Theoretical possibilities for the development of novel antiarrhythmic drugs.
Varró A; Biliczki P; Iost N; Virág L; Hála O; Kovács P; Mátyus P; Papp JG
Curr Med Chem; 2004 Jan; 11(1):1-11. PubMed ID: 14754422
[TBL] [Abstract][Full Text] [Related]
7. A mechanism for the potential proarrhythmic effect of acidosis, bradycardia, and hypokalemia on the blockade of human ether-a-go-go-related gene (HERG) channels.
Lin C; Cvetanovic I; Ke X; Ranade V; Somberg J
Am J Ther; 2005; 12(4):328-36. PubMed ID: 16041196
[TBL] [Abstract][Full Text] [Related]
8. The hERG channel activator, RPR260243, enhances protective
Shi YP; Pang Z; Venkateshappa R; Gunawan M; Kemp J; Truong E; Chang C; Lin E; Shafaattalab S; Faizi S; Rayani K; Tibbits GF; Claydon VE; Claydon TW
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H251-H261. PubMed ID: 32559136
[TBL] [Abstract][Full Text] [Related]
9. The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o.
Diaz GJ; Daniell K; Leitza ST; Martin RL; Su Z; McDermott JS; Cox BF; Gintant GA
J Pharmacol Toxicol Methods; 2004; 50(3):187-99. PubMed ID: 15519905
[TBL] [Abstract][Full Text] [Related]
10. [HERG K+ channel, the target of anti-arrhythmias drugs].
Guan FY; Yang SJ
Yao Xue Xue Bao; 2007 Jul; 42(7):687-91. PubMed ID: 17882949
[TBL] [Abstract][Full Text] [Related]
11. In silico screening of the impact of hERG channel kinetic abnormalities on channel block and susceptibility to acquired long QT syndrome.
Romero L; Trenor B; Yang PC; Saiz J; Clancy CE
J Mol Cell Cardiol; 2014 Jul; 72():126-37. PubMed ID: 24631769
[TBL] [Abstract][Full Text] [Related]
12. Febrile temperature facilitates hERG/IKr degradation through an altered K(+) dependence.
Zhao Y; Wang T; Guo J; Yang T; Li W; Koichopolos J; Lamothe SM; Kang Y; Ma A; Zhang S
Heart Rhythm; 2016 Oct; 13(10):2004-11. PubMed ID: 27321242
[TBL] [Abstract][Full Text] [Related]
13. Identification of IKr and its trafficking disruption induced by probucol in cultured neonatal rat cardiomyocytes.
Guo J; Massaeli H; Li W; Xu J; Luo T; Shaw J; Kirshenbaum LA; Zhang S
J Pharmacol Exp Ther; 2007 Jun; 321(3):911-20. PubMed ID: 17377062
[TBL] [Abstract][Full Text] [Related]
14. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
Thomas D; Karle CA; Kiehn J
Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
[TBL] [Abstract][Full Text] [Related]
15. The Susceptibilities of Human Ether-à-Go-Go-Related Gene Channel with the G487R Mutation to Arrhythmogenic Factors.
Hisajima N; Hata Y; Kinoshita K; Fukushima T; Nishida N; Kano M; Tabata T
Biol Pharm Bull; 2015; 38(5):781-4. PubMed ID: 25947924
[TBL] [Abstract][Full Text] [Related]
16. Rab11-dependent Recycling of the Human Ether-a-go-go-related Gene (hERG) Channel.
Chen J; Guo J; Yang T; Li W; Lamothe SM; Kang Y; Szendrey JA; Zhang S
J Biol Chem; 2015 Aug; 290(34):21101-21113. PubMed ID: 26152716
[TBL] [Abstract][Full Text] [Related]
17. Effects of L-type calcium channel and human ether-a-go-go related gene blockers on the electrical activity of the human heart: a simulation study.
Zemzemi N; Rodriguez B
Europace; 2015 Feb; 17(2):326-33. PubMed ID: 25228500
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the human ether-a-go-go-related gene (hERG) channel by Rab4 protein through neural precursor cell-expressed developmentally down-regulated protein 4-2 (Nedd4-2).
Cui Z; Zhang S
J Biol Chem; 2013 Jul; 288(30):21876-86. PubMed ID: 23792956
[TBL] [Abstract][Full Text] [Related]
19. Impact of ancillary subunits on ventricular repolarization.
Abbott GW; Xu X; Roepke TK
J Electrocardiol; 2007; 40(6 Suppl):S42-6. PubMed ID: 17993327
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action potential prolongation by RP 58866 and its active enantiomer, terikalant. Block of the rapidly activating delayed rectifier K+ current, IKr.
Jurkiewicz NK; Wang J; Fermini B; Sanguinetti MC; Salata JJ
Circulation; 1996 Dec; 94(11):2938-46. PubMed ID: 8941124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
